Pfizer Ltd. - Research Center
500680 PFIZER Group (A) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
1,106.57 |
1,230.37 |
1,225.56 |
1,385.43 |
1,110.30 |
Operating profit |
293.32 |
423.54 |
360.62 |
475.11 |
389.61 |
Interest |
5.60 |
7.02 |
6.03 |
4.46 |
7.72 |
Gross profit |
357.25 |
458.78 |
389.97 |
497.92 |
411.24 |
EPS (Rs) |
53.00 |
75.11 |
58.95 |
74.94 |
55.92 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
69.53 |
42.26 |
35.38 |
27.27 |
29.35 |
Stock adjustment |
24.75 |
14.70 |
-18.49 |
-54.41 |
10.99 |
Raw material |
169.89 |
184.67 |
163.34 |
190.95 |
156.33 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
183.32 |
174.68 |
202.04 |
201.63 |
172.11 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
435.29 |
432.78 |
518.05 |
572.15 |
381.26 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
30.98 |
52.76 |
60.77 |
54.23 |
54.87 |
Taxation |
83.78 |
114.99 |
59.50 |
100.83 |
100.55 |
Net profit / loss |
242.49 |
343.62 |
269.70 |
342.86 |
255.82 |
Extra ordinary item |
- |
52.59 |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
45.75 |
45.75 |
45.75 |
45.75 |
45.75 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
26.51 |
34.42 |
29.42 |
34.29 |
35.09 |
GPM (%) |
30.38 |
36.05 |
30.93 |
35.25 |
36.08 |
NPM (%) |
20.62 |
27.00 |
21.39 |
24.27 |
22.45 |